Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

THERATOPE

Known as: THERATOPE STn-KLH vaccine 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
Cancer vaccines have demonstrated that they can stimulate antibody and cell-mediated immune responses against tumor-associated… Expand
Is this relevant?
2004
2004
2547 Background: Theratope is an investigational therapeutic cancer vaccine consisting of a synthetic form of STn conjugated to… Expand
Is this relevant?
Review
2003
Review
2003
Mucin-1 (MUC-1) is a high-molecular-weight glycoprotein rich in serine and threonine residues that are O-glycosylated. Expression… Expand
Is this relevant?
2003
2003
The success of high-dose chemotherapy followed by autologous stem-cell rescue as treatment for breast and ovarian cancer is… Expand
Is this relevant?
Review
2003
Review
2003
The development of active specific immunotherapy depends on the identification of altered cancer cell-specific molecules or… Expand
Is this relevant?
Review
2001
Review
2001
Active specific immunotherapy (ASI) is a promising approach to treating cancer. Numerous studies in the laboratory have… Expand
Is this relevant?
2000
2000
The purpose of this study was to evaluate the toxicity and potential efficacy of administering the THERATOPE® STn-KLH cancer… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Review
2000
Review
2000
  • Michael Morse
  • Current opinion in molecular therapeutics
  • 2000
  • Corpus ID: 39168794
Active specific immunotherapy, the use of 'vaccines' to stimulate therapeutic tumor antigen-specific immune responses, holds… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
THERATOPE (Biomira Inc., Edmonton, AB, Canada) STn-KLH cancer vaccine induces strong antibody titers against both the synthetic… Expand
Is this relevant?
1996
1996
Abstract Patients with metastatic breast, colorectal or ovarian cancers received active specific immunotherapy (ASI) with… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?